Author:
Patel V.,Ormondroyd L.,Lyons A.,McGurk M.
Publisher
Springer Science and Business Media LLC
Reference13 articles.
1. Regaud C . On the sensitivity of bony tissue to gamma rays and the mechanism of osteoradionecrosis (in French). Comptes Rendus Hebdomadaires des Seances et Memoires de la Societe de Biologie 1922; 87: 629–932.
2. Jeraemic B, Shibamoto Y, Milicic B et al. Hyperfractionated radiation therapy with or without concurrent low-dose daily cisplatin in locally advanced squamous cell carcinoma of the head and neck: a prospective randomized trial. J Clin Oncol 2000; 18: 1458–1464.
3. Patel V, Gadiwalla Y, Sassoon I, Sproat C, Kwok J, McGurk M . Use of pentoxifylline and tocopherol in the management of osteoradionecrosis. Br J Oral Maxillofac Surg 2016; 54: 342–345.
4. Notani K, Yamazaki Y, Kitada H et al. Management of mandibular osteoradionecrosis corresponding to the severity of osteoradionecrosis and the method of radiotherapy. Head Neck 2003; 25: 181–186.
5. Nabil S, Samman N . Incidence and prevention of osteoradionecrosis after dental extraction in irradiated patients: a systematic review. Int J Oral Maxillofac Surg 2011; 40: 229–243.